Cumberland Pharmaceuticals shareholders re-elect directors, ratify auditor at annual meeting

CUMBERLAND PHARMACEUTICALS INC

Martin S. Brown, Jr. re-elected as Class II director with 96.0% of votes in favor (8,544,756 for, 352,239 withheld).
James R. Jones re-elected as Class II director with 94.5% of votes in favor (8,411,468 for, 485,527 withheld).
Ratification of Carr, Riggs & Ingram LLC as auditor for FY2024 passed with 99.9% of votes in favor (11,189,440 for, 15,502 against).

item 5.07

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

CUMBERLAND PHARMACEUTICALS INC shareholders approved Election of two Class II Directors at the 2024-04-23 meeting.

Proposal: director election
Outcome: passed
Meeting: 2024-04-23

Exact text from the filing

For Against Withheld Abstentions % of Votes in Favor Martin S. Brown, Jr. 8,544,756 — 352,239 — 96.0% James R. Jones 8,411,468 — 485,527 — 94.5%

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

CUMBERLAND PHARMACEUTICALS INC shareholders approved Ratification of appointment of Carr, Riggs & Ingram, LLC as independent registered public accounting firm for year ending December 31, 2024 at the 2024-04-23 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2024-04-23

Exact text from the filing

Appointment of Carr, Riggs & Ingram LLC as our independent registered public accounting firm for the year ending December 31, 2024 11,189,440 15,502 — 28,560 99.9%

View on SEC.gov

182 shareholder votes filed in the last 30 days. Browse all shareholder votes →

CUMBERLAND PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001628280-24-019053

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.